Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas.
- DOI
- 10.1016/j.ejca.2012.05.009
- Published
- 2012 Nov
- Container
- European journal of cancer (Oxford, England : 1990)
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejca.2012.05.009,
title = {Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas.},
author = {Asmane I and Watkin E and Alberti L and Duc A and Marec-Berard P and Ray-Coquard I and Cassier P and Decouvelaere AV and Ranchère D and Kurtz JE and Bergerat JP and Blay JY},
year = {2012},
journal = {European journal of cancer (Oxford, England : 1990)},
doi = {10.1016/j.ejca.2012.05.009},
url = {https://doi.org/10.1016/j.ejca.2012.05.009}
}RIS
TY - JOUR TI - Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas. AU - Asmane I AU - Watkin E AU - Alberti L AU - Duc A AU - Marec-Berard P AU - Ray-Coquard I AU - Cassier P AU - Decouvelaere AV AU - Ranchère D AU - Kurtz JE AU - Bergerat JP AU - Blay JY PY - 2012 JO - European journal of cancer (Oxford, England : 1990) DO - 10.1016/j.ejca.2012.05.009 UR - https://doi.org/10.1016/j.ejca.2012.05.009 ER -
APA
I, A., E, W., L, A., A, D., P, M., I, R., P, C., AV, D., D, R., JE, K., JP, B., & JY, B. (2012). Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas.. European journal of cancer (Oxford, England : 1990). https://doi.org/10.1016/j.ejca.2012.05.009
Source records
- pubmed · retrieved 2026-09-27T00:40:28.723Z
- europe-pmc · retrieved 2026-09-27T00:40:28.818Z
- hal · retrieved 2026-09-27T00:40:28.817Z